To cite this paper use one of the standards below:
The human nail is a unique keratinized barrier that can be affected by various disorders, such as onychomycosis and psoriasis1, 2. Systemic oral therapy has been used to treat these diseases, but presents disadvantages related to side effects, drug interactions, contraindications, toxicity, high cost and low patient compliance. Topical drug administration is an interesting approach to overcome these drawbacks. However, nail composition, reduced diffusion through ungual route and low tissue bioavailability are limiting problems for topical therapies. To favor permeation of topically applied treatments, penetration enhancers may be employed. The aim of this research was to perform a patent survey (2008 – 2018) concerning permeation enhancers applied to nail drug delivery to the treatment of onychomycosis and psoriasis. The patent search revealed that permeation enhancers, particularly chemicals, including solvents, keratolytic agents, enzymes, etching agents, among others, are excellent strategies for promoting ungual delivery of drugs.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper